Probiotics, D–Lactic acidosis, oxidative stress and strain specificity

Gut Microbes

Volumn 8, Issue 4, 2017, Pages 311-322

  Vitetta, Luis ^a,b   Coulson, Samantha ^a   Thomsen, Michael ^a,b   Nguyen, Tony ^b   Hall, Sean ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Medlab   (Australia)

Author keywords

bacteria; D Lactate; efficacy; oxidative stress; probiotics; safety; strain

Indexed keywords

BETA CATENIN; FORMYLPEPTIDE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTIC ACID; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;

BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; CHRONIC FATIGUE SYNDROME; COMMENSAL; GENE SEQUENCE; GENOMIC INSTABILITY; HUMAN; LACTIC ACID BACTERIUM; LACTIC ACIDOSIS; META ANALYSIS (TOPIC); METABOLITE; NONHUMAN; NOTE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); ANIMAL; CLASSIFICATION; LACTOBACILLACEAE; METABOLISM; PHYSIOLOGY; SPECIES DIFFERENCE;

ACIDOSIS, LACTIC; ANIMALS; HUMANS; LACTOBACILLACEAE; OXIDATIVE STRESS; PROBIOTICS; SPECIES SPECIFICITY;

EID: 85011681738     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2017.1279379     Document Type: Note

References (66)

1. Rogers NJ, Mousa SA. The shortcomings of clinical trials assessing the efficacy of probiotics in irritable bowel syndrome. J Alt Comp Med (New York, NY) 2012; 18(2):112-9; http://dx.doi.org/10.1089/acm.2011.0015
2. Dhingra K. Methodological issues in randomized trials assessing probiotics for periodontal treatment. J Periodontal Res 2012; 47(1):15-26; PMID:21777405; http://dx.doi.org/10.1111/j.1600-0765.2011.01399.x
3. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health 2014; 9(3):584-671; http://dx.doi.org/10.1002/ebch.1976
4. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2015; 2:Cd006895
5. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, Guyatt GH, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013; 5:Cd006095
6. Fuller, R (Ed). Probiotics:The scientific basis. Berlin/Heidelberg:Springer Science+Business Media; 1992, pp. 377–85.
7. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11(8):506-14; PMID:24912386; http://dx.doi.org/10.1038/nrgastro.2014.66
8. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Trans Med 2014; 6(237):237ra65; http://dx.doi.org/10.1126/scitranslmed.3008599
9. Sanders ME. Probiotics:definition, sources, selection, and uses. Clin Infect Dis 2008; 46(Suppl 2):S58-61; discussion S144–51; PMID:18181724
10. Makarova KS, Koonin EV. Evolutionary genomics of lactic acid bacteria. J Bacteriol 2007; 189(4):1199-208; PMID:17085562; http://dx.doi.org/10.1128/JB.01351-06
11. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2017; 45(D1):D12-7.
12. Fu J, Qin QW. Pan-genomics analysis of 30 Escherichia coli genomes]. Yi Chuan 2012; 34(6):765-72; PMID:22698749; http://dx.doi.org/10.3724/SP.J.1005.2012.00765
13. Shanahan F. Probiotics:a perspective on problems and pitfalls. Scand J Gastroenterol Suppl 2003; 237:34-6
14. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice:what are the risks? Am J Clin Nutr 2006; 83(6):1256-64; PMID:16762934
15. Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics:are mixtures more effective than single strains? Eur J Nutr 2011; 50(1):1-17; PMID:21229254; http://dx.doi.org/10.1007/s00394-010-0166-z
16. Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics:an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 2003; 17(5):725-40; PMID:14507584; http://dx.doi.org/10.1016/S1521-6918(03)00055-6
17. Hill C, Sanders ME. Rethinking “probiotics”. Gut Microbes 2013; 4(4):269-70; PMID:23778363; http://dx.doi.org/10.4161/gmic.25143
18. Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics–A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96(3):219-33; PMID:15454313; http://dx.doi.org/10.1016/j.ijfoodmicro.2004.05.012
19. Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S, Kautiainen H, Julkunen I, Vapaatalo H, Korpela R. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 2008; 14(13):2029-36; PMID:18395902; http://dx.doi.org/10.3748/wjg.14.2029
20. Sybesma W, Molenaar D, van IJcken W, Venema K, Kort R. Genome instability in Lactobacillus rhamnosus GG. App Environ Microbiol 2013; 79(7):2233-9; http://dx.doi.org/10.1128/AEM.03566-12
21. Segers ME, Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG–host interactions. Microb Cell Fact 2014; 13(Suppl 1):S7; PMID:25186587; http://dx.doi.org/10.1186/1475-2859-13-S1-S7
22. Lebeer S, Claes I, Tytgat HL, Verhoeven TL, Marien E, von Ossowski I, Reunanen J, Palva A, Vos WM, Keersmaecker SC, et al. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 2012; 78(1):185-93; PMID:22020518; http://dx.doi.org/10.1128/AEM.06192-11
23. Tripathi P, Beaussart A, Alsteens D, Dupres V, Claes I, von Ossowski I, de Vos WM, Palva A, Lebeer S, Vanderleyden J, et al. Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG. ACS Nano 2013; 7(4):3685-97; PMID:23531039; http://dx.doi.org/10.1021/nn400705u
24. Vancanneyt M, Huys G, Lefebvre K, Vankerckhoven V, Goossens H, Swings J. Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin. Appl Environ Microbiol 2006; 72(8):5376-83; PMID:16885289; http://dx.doi.org/10.1128/AEM.00091-06
25. Douillard FP, Ribbera A, Jarvinen HM, Kant R, Pietilä TE, Randazzo C, Paulin L, Laine PK, Caggia C, von Ossowski I, et al. Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics. Appl Environ Microbiology 2013; 79(6):1923-33; http://dx.doi.org/10.1128/AEM.03467-12
26. EFSA. Panel on Dietetic Products, Nutrition and Allergies (NDA). General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims. EFSA 2011; 9:2135; http://dx.doi.org/10.2903/j.efsa.2011.2135
27. Ouwehand AC SS. In vitro adhesion assays for probiotics and their in vivo relevance:a review. Microb Ecol Health Dis 2003; 15:175-84; http://dx.doi.org/10.1080/08910600310019886
28. Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol 1997; 24(5):361-4; PMID:9172443; http://dx.doi.org/10.1046/j.1472-765X.1997.00140.x
29. Sanders ME. Impact of probiotics on colonizing microbiota of the gut. J Clin Gastroenterol 2011; 45(Suppl):S115-9; PMID:21992949; http://dx.doi.org/10.1097/MCG.0b013e318227414a
30. Papagaroufalis K, Fotiou A, Egli D, Tran LA, Steenhout P. A randomized double blind controlled safety trial evaluating D-lactic acid production in healthy infants fed a lactobacillus reuteri-containing formula. Nutr Metab Insights 2014; 7:19-27; PMID:24812520
31. Haschke-Becher E, Brunser O, Cruchet S, Gotteland M, Haschke F, Bachmann C. Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii with formula. Ann Nutr Metab 2008; 53(3–4):240-4; PMID:19088469; http://dx.doi.org/10.1159/000185642
32. Cekola PL, Czerkies LA, Storm HM, Wang MH, Roberts J, Saavedra JM. Growth and Tolerance of Term Infants Fed Formula With Probiotic Lactobacillus reuteri. Clin Pediatr (Phila) 2015; 54(12):1175-84; PMID:25758426; http://dx.doi.org/10.1177/0009922815574076
33. Connolly E, Abrahamsson T, Bjorksten B. Safety of D(−)-lactic acid producing bacteria in the human infant. J Pediatr Gastroenterol Nutr 2005; 41(4):489-92; PMID:16205524; http://dx.doi.org/10.1097/01.mpg.0000176179.81638.45
34. von Wright A AL. Lactic acid bacteria:microbiological and functional aspects. 4th ed. Lahtinen S OA, Salminen S, von Wright A, editor. Florida, U.S.A.:Taylor and Francis; 2012 2012. pp.761 p
35. Sheedy JR, Wettenhall RE, Scanlon D, Gooley PR, Lewis DP, McGregor N, Stapleton DI, Butt HL, DE Meirleir KL. Increased D-lactic acid intestinal bacteria in patients with chronic fatigue syndrome. In vivo 2009; 23(4):621-8; PMID:19567398
36. Ewaschuk JB, Naylor JM, Zello GA. D-lactate in human and ruminant metabolism. J Nutr 2005; 135(7):1619-25; PMID:15987839
37. Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore) 1998; 77(2):73-82; PMID:9556700; http://dx.doi.org/10.1097/00005792-199803000-00001
38. Carr FJ, Chill D, Maida N. The lactic acid bacteria:a literature survey. Crit Rev Microbiol 2002; 28(4):281-370; PMID:12546196; http://dx.doi.org/10.1080/1040-840291046759
39. Coulson S, Butt H, Vecchio P, Gramotnev H, Vitetta L. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis:therapeutic efficacy and effeects on gastrointestinal microbiota profiles. Inflammopharmacology 2013; 21:79-90; PMID:22821424; http://dx.doi.org/10.1007/s10787-012-0146-4
40. de Vrese M, Barth CA. Postprandial plasma D-lactate concentrations after yogurt ingestion. Z Ernahrungswiss 1991; 30(2):131-7; PMID:1897274; http://dx.doi.org/10.1007/BF01610068
41. Barreto FM, Colado Simao AN, Morimoto HK, Batisti Lozovoy MA, Dichi I, Helena da Silva Miglioranza L. Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition 2013; 30:939-942; PMID:24613434; http://dx.doi.org/10.1016/j.nut.2013.12.004
42. Lenoir-Wijnkoop I, Nuijten MJ, Craig J, Craig J, Butler CC. Nutrition economic evaluation of a probiotic in the prevention of antibiotic associated diarrhea. Front Pharmacol 2014; 5(13):1-8; PMID:24596556; http://dx.doi.org/10.3389/fphar.2014.00013
43. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, Nakhjavani MR, Mohtadi-Nia J. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients:A randomized double-blind clinical trial. Int J Rheum Dis 2014; 17:519-527; PMID:24673738
44. Tomasz B, Zoran S, Jroslaw W, Ryszard M, Marcin G, Robert B, Piotr K, Lukasz K, Jacek P, Piotr G, et al. Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis:A randomized prospective study. Biomed Res Int 2014; 2014:208064; PMID:24579075
45. Betta P. Not all probiotics are the same:Gut microbiota modulation with a multistrain probiotics. N Am J Med Sci 2014; 6:58-59; PMID:24678480; http://dx.doi.org/10.4103/1947-2714.125871
46. Sepp E, Lõivukene K, Julge K, Voor T, Mikelsaar M. The association of gut microbiota with body weight and body mass index in preschool children of Estonia. Microb Ecol Health Dis 2013; 24:1-8
47. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, Oh W. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115(1):1-4; PMID:15629973
48. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, Tsao LY, Chen CH, Su BH. Oral probiotics prevent necrotizing enterocolitits in very low birth weight preterm infants:a multicenter, randomized controllled trial. Pediatrics 2008; 122(4):693-700; PMID:18829790; http://dx.doi.org/10.1542/peds.2007-3007
49. Samanta M, Sarkar M, Ghosh P, Ghosh, Jk, Sinha, Mk, Chatterjee S. Prophylatic probioitcs for prevention of necrotizinfg enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55(2):128-31; PMID:18842610; http://dx.doi.org/10.1093/tropej/fmn091
50. Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, Parameswaran N, McCabe LR, Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol 2014; 229:1822-30; PMID:24677054; http://dx.doi.org/10.1002/jcp.24636
51. Laleman I, Detailleur V, Slot DE, Slomka V, Quirynen M, Teughels W. Probiotics reduce mutans streptococci counts in humans:A systematic review and meta-analysis. Clin Oral Investig 2014; 18:1539-52; PMID:24663813; http://dx.doi.org/10.1007/s00784-014-1228-z
52. Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, Perez LA, Rojas C, Ovalle O, Garcia-Harker JE, Tamayo ME, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012; 130(5):e1113-20; PMID:23071204; http://dx.doi.org/10.1542/peds.2011-3584
53. Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F, Betta P. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns:incidence of late-onset sepsis and neurological outcome. J Perinatol 2011; 31(1):63-9; PMID:20410904; http://dx.doi.org/10.1038/jp.2010.57
54. Martarelli D, Verdenelli MC, Scuri S, Cocchioni M, Silvi S, Cecchini C, Pompei P. Effect of a probioitc intake on oxidant and antioxidant paramters in plasma of athletes during intense exercise training. Curr Microbiol 2011; 62(6):1689-96; PMID:21400082; http://dx.doi.org/10.1007/s00284-011-9915-3
55. Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, Prajapati J. Probiotics as potential antioxidants:a systematic review. J Agric Food Chem 2015; 63(14):3615-26; PMID:25808285; http://dx.doi.org/10.1021/jf506326t
56. Vitetta L, Briskey D, Hayes E, Shing C, Peake J. A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology 2012; 20(5):251-66; PMID:22427210; http://dx.doi.org/10.1007/s10787-012-0126-8
57. Holstrom KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol 2014; 15(6):411-21; PMID:24854789; http://dx.doi.org/10.1038/nrm3801
58. Jones RM, Luo L, Ardita CS, Richardson AN, Kwon YM, Mercante JW, Alam A, Gates CL, Wu H, Swanson PA, et al. Symbiotic lactobacillu stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 2013; 32(23):3017-28; PMID:24141879; http://dx.doi.org/10.1038/emboj.2013.224
59. Neish AS. Redox signaling mediated by the gut microbiota. Free Radic Res 2013; 47(11):950-7; PMID:23937589; http://dx.doi.org/10.3109/10715762.2013.833331
60. Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab 2012; 61(2):160-74; PMID:23037511; http://dx.doi.org/10.1159/000342079
61. Lee WJ. Bacterial-modulated signaling pathways in gut homeostasis. Sci Signal 2008; 1(21):pe24; PMID:18506033; http://dx.doi.org/10.1126/stke.121pe24
62. Lin PW, Myers LE, Ray L, Song SC, Nasr TR, Berardinelli AJ, Kundu K, Murthy N, Hansen JM, Neish AS. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 2009; 47(8):1205-11; PMID:19660542; http://dx.doi.org/10.1016/j.freeradbiomed.2009.07.033
63. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132(2):562-75; PMID:17258729; http://dx.doi.org/10.1053/j.gastro.2006.11.022
64. Bosch M, Fuentes MC, Audivert S, Bonachera MA, Peiró S, Cuñé J. Lactobacillus plantarum CECT 7527, 7528 and 7529:probiotic candidates to reduce cholesterol levels. J Sci Food Agric 2014; 94(4):803-9; PMID:24186773; http://dx.doi.org/10.1002/jsfa.6467
65. Preidis GA, Saulnier DM, Blutt SE, Mistretta TA, Riehle KP, Major AM, Venable SF, Finegold MJ, Petrosino JF, Conner ME, et al. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine’. FASEB J 2012; 26(5):1960-9; PMID:22267340; http://dx.doi.org/10.1096/fj.10-177980
66. Ardita CS, Mercante JW, Kwon YM, Luo L, Crawford ME, Powell DN, Jones RM, Neish AS. Epithelial adhesion mediated by pilin SpaC is required for Lactobacillus rhamnosus GG-induced cellular responses. Appl Environ Microbiol 2014; 80(16):5068-77; PMID:24928883; http://dx.doi.org/10.1128/AEM.01039-14